MedPath

Comparison of two approaches of sciatic nerve block via ultrasound guidance

Phase 3
Conditions
Health Condition 1: S92- Fracture of foot and toe, except ankleHealth Condition 2: S82- Fracture of lower leg, including ankle
Registration Number
CTRI/2023/03/050911
Lead Sponsor
PGIMER Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients between age group 18-80 years undergoing below knee surgeries, ASA physical status I-III

Exclusion Criteria

Patient refusal for nerve blocks, Allergy to amide local anaesthetic drugs, Chronic opioid therapy ( >60 mg morphine daily or equivalent), Patients with thrombocytopenia/coagulopathy, on anti-coagulant and thrombolytic therapy, Morbid obesity (BMI >35 with obesity symptoms or BMI > 40), Neurological diseases, Local or systemic infection, Patients with psychiatric illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to perform the blockTimepoint: (time interval from the contact of USG probe with the patient to the end of local anaesthetic injection)
Secondary Outcome Measures
NameTimeMethod
1. Block onset timeTimepoint: time interval from the end of local anaesthetic injection to the achievement of complete sensory blockade of both saphenous and sciatic nerve;2.Number of needle passesTimepoint: During performance of procedure;3.Level of procedure related painTimepoint: During performance of procedure;4.Sciatic nerve visibility score and depth from skinTimepoint: During performance of procedure;5.Visual analog scale (VAS) scoresTimepoint: immediate post-operation (T1), at 2 hours (T2), 4 hours (T3), 8 hours (T4), 12 hours (T5), 16 hours (T6), 24 hours (T7), and 48 hours (T8);6.Time to first rescue analgesiaTimepoint: during 48 hr follow up;7.48 hour rescue analgesic consumptionTimepoint: during 48 hr follow up;8.Occurrence of any adverse events/complicationsTimepoint: during 48 hr follow up
© Copyright 2025. All Rights Reserved by MedPath